Ireland· IE-PA-PA1009/026/001

Cortiment 9 mg prolonged release tablets

A budesonide product containing budesonide, registered in Ireland by Ferring Ireland Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC A07EA06

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about budesonideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Budesonide is registered in 16 of 19 countries.

Countries holding a registration under ATC A07EA06 (budesonide), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search budesonide products by name

Budesonide · ATC A07EA06

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of budesonide costs, country by country.

Normalised to the WHO defined daily dose (9 mg), the median price runs from $2.36 in Italy to $4.97 in Switzerland — a ×2.1 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Budesonide · price per daily dose (9 mg)

USD · FX 28 Sept 2026

CH Switzerland$4.97
IT Italy$2.36

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Budesonide
Manufacturer: Ferring Ireland Ltd
Country: Ireland (IE)
ATC code: A07EA06
ATC class: Budesonide
Defined daily dose: 9 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA1009/026/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

687 interactions on record for budesonide.

Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check budesonide against other medicines How interaction checks work

Budesonide · interactions on record

687 records

62 severe
260 moderate
27 minor
337 info

Most severe, free to view

LonafarnibA16AX20severe
ConivaptanC03XA02severe
Bempedoic acidC10AX15severe
MifepristoneG03XB01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Budesonide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All budesonide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Budenofalk, Budo-San
Belgium · Budenofalk, Budesonid Sandoz
Bulgaria · Airbudenid, Буденофалк
Cyprus · Axelovert, Biosonide
Czechia · Budenofalk, Budenofalk Uno
Germany · Aquacort, Budapp Nasal
Denmark · Benarhin, Budenofalk
Estonia · Budesonid Sandoz, Budesonide
Spain · Budena, Budesonida
Finland · Budenofalk, Budesonid Easyhaler Orion
France · Budésonide Arrow, Budesonide Biogaran
United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
Greece · Aurid, Axelovert
Croatia · Budelin Novolizer, Budosan
Hungary · Budenofalk, Budesonid Easyhaler
Iceland · Budesonide Stada, Cortiment
Italy · Aircort, Bidien
Liechtenstein · Jorveza, Kinpeygo
Lithuania · Budenofalk, Budesonide Ferring
Luxembourg · Budenofalk, Budesonide Eg
Latvia · Budenofalk, Budesonid Sandoz
Malta · Budesonida Aldo-Unión, Budesonide Azure
Netherlands · Budenofalk, Budenofalk Schuim
Norway · Budenofalk, Budesonid Medical Valley
Poland · Bds N, Benodil
Portugal · Aeromax, Budenofalk
Romania · Budenofalk, Budenofalk Uno
Sweden · Budaxiro, Budenofalk
Slovenia · Budenofalk, Budesonid Easyhaler Orion
Slovakia · Budelin Novolizer, Budenofalk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/7e2e72f3-d1cb-48d6-afa8-ab42e7502708
GET /v1/drugs/7e2e72f3-d1cb-48d6-afa8-ab42e7502708?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A07EA",
    "A07EA06"
  ],
  "strength": null,
  "pa_number": "PA1009/026/001",
  "substances": [
    "Budesonide"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "05/12/2014",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about budesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console